Literature DB >> 22299661

The effect of different dialysate magnesium concentrations on QTc dispersion in hemodialysis patients.

Farsad Afshinnia1, Hardik Doshi, Panduranga S Rao.   

Abstract

BACKGROUND: Electrolyte changes during dialysis affect corrected QT (QTc) and QTc dispersion (QTcd), a surrogate marker of arrhythmogenicity. The impact of magnesium on QTcd is not clear.
METHODS: Twenty-two stable patients on maintenance hemodialysis were enrolled in this study. Each underwent two consecutive hemodialysis sessions at least 2 days apart, the first against normal magnesium dialysate (with magnesium at 1.8 mg/dL) followed by a low magnesium dialysate (with magnesium at 0.6 mg/dL). Pre- and post-dialysis weights, blood pressure, electrolytes, and 12-lead surface EKG were recorded. The QT interval and the QTcd were calculated before and after dialysis in both sessions.
RESULTS: Of 22 patients, 16 were female. The mean age ± SD was 53.7 ± 18.0 years. The mean change of QTcd (pre- vs. post-dialysis) was 9.5 ms (p = 0.120) and 9.3 ms (p = 0.145) in low and normal magnesium groups, respectively. Using univariate analysis, there was a statistically significant decrease in the mean blood pressure, weight, potassium, magnesium, and QTc interval post-dialysis (compared to pre-dialysis) in both groups (p ≤ 0.049). Post-dialysis concentrations of sodium and calcium were unchanged (compared to pre-dialysis) but bicarbonate increased with both dialysate groups (p < 0.001). The mean change of QTcd was not significant pre- versus post-dialysis by univariate analysis in either group. Multiple linear regression analysis adjusting for pertinent factors did not change the results in either of the two groups.
CONCLUSION: Using a low magnesium dialysate bath in hemodynamically stable hemodialysis patients without preexisting advanced cardiac disease does not significantly impact QTcd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22299661      PMCID: PMC4861151          DOI: 10.3109/0886022X.2012.656561

Source DB:  PubMed          Journal:  Ren Fail        ISSN: 0886-022X            Impact factor:   2.606


  27 in total

1.  Use of the QTc interval and QTc dispersion in patients on haemodialysis: assessment of reproducibility.

Authors:  John Kyriazis; Vasilios Pikounis; Nikolaos Smirnioudis
Journal:  Nephrol Dial Transplant       Date:  2004-02       Impact factor: 5.992

2.  Changes in the corrected QT interval and corrected QT dispersion during haemodialysis.

Authors:  M Howse; S Sastry; G M Bell
Journal:  Postgrad Med J       Date:  2002-05       Impact factor: 2.401

3.  Free magnesium in patients on regular dialysis treatment.

Authors:  E Paskalev; M Genova
Journal:  Nephron       Date:  1999       Impact factor: 2.847

4.  Sodium channel block with mexiletine is effective in reducing dispersion of repolarization and preventing torsade des pointes in LQT2 and LQT3 models of the long-QT syndrome.

Authors:  W Shimizu; C Antzelevitch
Journal:  Circulation       Date:  1997-09-16       Impact factor: 29.690

5.  Cardiac arrhythmia in chronic renal failure: Holter monitoring during hemodialysis and intermittent peritoneal dialysis.

Authors:  E Grushka; J Garty; B Kristal; E Goldhammer; E G Abineder; S M Shasha
Journal:  Isr J Med Sci       Date:  1990-07

6.  The importance of bioimpedance (BIA) analysis and Cardio Tens (24-h ABPM and ECG) monitoring in the dialysis programme.

Authors:  L Löcsey; B Szlanka; I Ménes; A Kövér; E Vitai; Z Malkócs; P Keresztes; G Paragh
Journal:  Int Urol Nephrol       Date:  1999       Impact factor: 2.370

7.  Haemodialysis increases QT(c) interval but not QT(c) dispersion in ESRD patients without manifest cardiac disease.

Authors:  Adrian Covic; Mirela Diaconita; Paul Gusbeth-Tatomir; Maria Covic; Adrian Botezan; Gabriel Ungureanu; David J Goldsmith
Journal:  Nephrol Dial Transplant       Date:  2002-12       Impact factor: 5.992

8.  Value of corrected QT interval dispersion in identifying patients initiating dialysis at increased risk of total and cardiovascular mortality.

Authors:  Eliot R Beaubien; George B Pylypchuk; Jawad Akhtar; H Jay Biem
Journal:  Am J Kidney Dis       Date:  2002-04       Impact factor: 8.860

Review 9.  Magnesium in dialysis patients: serum levels and clinical implications.

Authors:  J F Navarro-González
Journal:  Clin Nephrol       Date:  1998-06       Impact factor: 0.975

10.  Cardiac arrhythmias in hemodialysis patients. A study of incidence and contributory factors.

Authors:  K Kimura; K Tabei; Y Asano; S Hosoda
Journal:  Nephron       Date:  1989       Impact factor: 2.847

View more
  4 in total

1.  Hemodialysis-induced repolarization abnormalities on ECG are influenced by serum calcium levels and ultrafiltration volumes.

Authors:  Hande Ozportakal; Abdullah Ozkok; Ozlem Alkan; Ahmet Sait Bulut; Memduha Boyraz; Mehmet Inanir; Goksel Acar; Ali Riza Odabas
Journal:  Int Urol Nephrol       Date:  2016-12-10       Impact factor: 2.370

Review 2.  Laboratory markers of ventricular arrhythmia risk in renal failure.

Authors:  Ioana Mozos
Journal:  Biomed Res Int       Date:  2014-05-26       Impact factor: 3.411

3.  The assessment of P-wave dispersion and myocardial repolarization parameters in patients with chronic kidney disease.

Authors:  Korhan Kollu; Lutfullah Altintepe; Cevdet Duran; Mustafa Topal; Samil Ecirli
Journal:  Ren Fail       Date:  2018-11       Impact factor: 2.606

4.  A high magnesium concentration in citrate dialysate prevents oxidative stress and damage in human monocytes in vitro.

Authors:  Carmen Vida; Julia Carracedo; Patricia de Sequera; Guillermo Bodega; Rafael Pérez; Matilde Alique; Rafael Ramírez
Journal:  Clin Kidney J       Date:  2020-08-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.